Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.23M Buy
3,399
+10
+0.3% +$3.42K 0.07% 131
2026
Q1
$1.19M Buy
3,389
+99
+3% +$35.3K 0.08% 113
2025
Q4
$1.08M Buy
3,290
+435
+15% +$138K 0.07% 132
2025
Q3
$806K Buy
2,855
+74
+3% +$21.5K 0.06% 166
2025
Q2
$777K Sell
2,781
-7
-0.3% -$1.98K 0.06% 163
2025
Q1
$869K Buy
2,788
+492
+21% +$145K 0.07% 119
2024
Q4
$598K Sell
2,296
-53
-2% -$15.7K 0.05% 164
2024
Q3
$757K Buy
2,349
+76
+3% +$24.9K 0.07% 128
2024
Q2
$710K Buy
2,273
+128
+6% +$37.6K 0.07% 117
2024
Q1
$610K Sell
2,145
-26
-1% -$7.61K 0.06% 136
2023
Q4
$625K Buy
2,171
+57
+3% +$15.5K 0.07% 115
2023
Q3
$568K Buy
2,114
+150
+8% +$37.4K 0.07% 113
2023
Q2
$436K Buy
1,964
+293
+18% +$68K 0.06% 154
2023
Q1
$404K Buy
1,671
+555
+50% +$136K 0.06% 147
2022
Q4
$293K Sell
1,116
-137
-11% -$36.7K 0.05% 147
2022
Q3
$282K Sell
1,253
-13
-1% -$3.15K 0.05% 138
2022
Q2
$308K Buy
1,266
+255
+25% +$62.5K 0.06% 134
2022
Q1
$244K Buy
1,011
+147
+17% +$33.8K 0.04% 170
2021
Q4
$194K Buy
+864
New +$182K 0.04% 200
2021
Q3
Sell
-733
Closed -$179K 212
2021
Q2
$179K Buy
+733
New +$180K 0.04% 181

Other funds holding AMGN

PDS Planning's AMGN Position: Q2 2026 in Review

PDS Planning increased its Amgen (AMGN) stake by 0.3% in Q2 2026, buying an estimated $3.42K and bringing the position to 3,399 shares worth $1.23M. The position accounts for 0.07% of the portfolio, ranked #131.

PDS Planning first reported a position in AMGN in Q2 2021 and has held it in 20 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • PDS Planning held 3,399 shares of Amgen worth $1.23M as of Q2 2026.
  • PDS Planning bought 10 Amgen shares in Q2 2026, an estimated $3.42K.
  • Amgen made up 0.07% of PDS Planning's portfolio in Q2 2026, its #131 holding.
  • PDS Planning first reported a position in Amgen in Q2 2021 and has held it in 20 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on PDS Planning's 13F filing for Q2 2026, filed 5 Aug 2026.